“ Thus, in spite of potential serious adverse effects of these drugs, a therapeutic trial may be justified in individual cases at an early stage hair loss with tamoxifen Recently, it has also been recognized that a number of common medications may potentially interfere with the angiogenic process, 15 including drugs that are commonly used in cardiac patients, such as spironolactone, 16 captopril, 17 isosorbide dinitrate, 18 lovastatin, 19 bumetanide, and furosemide ”